Pharmacoeconomics of obesity in China: a scoping review

Chen, Zhuo, Jiang, Shan, Wang, Youfa, Khan, M. Mahmud, Zhang, Donglan, Rajbhandari-Thapa, Janani and Li, Li (2021) Pharmacoeconomics of obesity in China: a scoping review. Expert Review of Pharmacoeconomics & Outcomes Research, 21 (2). pp. 173-181. ISSN 1473-7167

PDF - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
Available under Licence Creative Commons Attribution.
Download (946kB) | Preview


Background: With the growing rate of obesity and associated chronic conditions in China, there is a need to assess the health and economic burdens of obesity and examine the effectiveness of pharmaceutical, medical, and comprehensive weight-loss interventions. Areas covered: This article reviewed publications retrieved from PubMed and Google Scholar during 2010–2020 on pharmacoeconomic studies related to overweight and obesity in China. We identified five cost-of-illness studies and four cost-effectiveness analyses of weight-loss interventions, including bariatric surgeries and a comprehensive intervention program. Expert opinion: There is a lack of pharmacoeconomic analyses of obesity in China. Existing studies have often taken the health system perspective without accounting for productivity loss. Cohort studies and studies based on electronic health records or claims data are needed to provide the epidemiologic parameters required for homegrown economic evaluations of the health and economic burdens of obesity in China, as well as the cost-effectiveness of interventions to reduce obesity and its sequela.

Item Type: Article
Keywords: Bariatric surgery; China; cost-effectiveness; cost-of-illness; economic evaluation; obesity; overweight
Schools/Departments: University of Nottingham Ningbo China > Faculty of Humanities and Social Sciences > School of Economics
Identification Number:
Depositing User: Yu, Tiffany
Date Deposited: 07 May 2021 08:55
Last Modified: 07 May 2021 08:55

Actions (Archive Staff Only)

Edit View Edit View